Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Oncology Drug Safety Is Key Focus In US FDA’s Generic Label Updates

Feb 21 2020

• By Michael McCaughan

Related Content

US FDA Still Seeking Sponsor Cooperation For Oncology Label Updates

Feb 21 2020

Cancer Drugs: US FDA Looks Outside For Help On Generic Labeling Updates

Apr 11 2019

Project Renewal: US FDA's Plan To Update Generic Cancer Drug Labels Depends On NDA Holders

Nov 28 2018

China Unlikely To Be Included In US FDA's Project Orbis In The Near Term

Feb 11 2020

Additional Topics

United States Generic Drugs Safety Regulation Drug Review Drug Safety Cancer BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window